Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.6%

9 terminated/withdrawn out of 552 trials

Success Rate

93.7%

+7.1% vs industry average

Late-Stage Pipeline

10%

53 trials in Phase 3/4

Results Transparency

2%

3 of 133 completed trials have results

Key Signals

104 recruiting3 with results7 withdrawn

Enrollment Performance

Analytics

N/A
217(58.2%)
Phase 2
62(16.6%)
Phase 1
33(8.8%)
Phase 4
29(7.8%)
Phase 3
24(6.4%)
Early Phase 1
8(2.1%)
373Total
N/A(217)
Phase 2(62)
Phase 1(33)
Phase 4(29)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (552)

Showing 20 of 552 trials
NCT07854002Not Yet Recruiting

Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study

Role: collaborator

NCT05444998Phase 2Completed

Neoadjuvant Inetetamab and Pyrotinib and Nab-paclitaxel for HER2+Breast Cancer

Role: lead

NCT05544071Not ApplicableCompleted

Individualized dlPFC-NAcc Modulation for Anhedonia in adMDD

Role: lead

NCT07822776Phase 2Recruiting

Efgartigimod in Anti-NMDA Receptor Encephalitis.

Role: collaborator

NCT06788743Not ApplicableCompleted

Impact of Sevoflurane Versus Propofol on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled Trial

Role: lead

NCT07819604Phase 2Not Yet Recruiting

Serplulimab Combined With CAPOX and Bevacizumab as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Role: lead

NCT06619912Phase 3Completed

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients

Role: lead

NCT06576921Phase 2Active Not Recruiting

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Role: lead

NCT07809178Not Yet Recruiting

China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm

Role: collaborator

NCT07806370Recruiting

A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing Immediate Post-Procedural Slow-Flow/No-Reflow in Acute ST-Elevation Myocardial Infarction Patients With High Thrombus Burden

Role: lead

NCT07252297Not ApplicableActive Not Recruiting

The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

Role: lead

NCT06979869Recruiting

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma

Role: lead

NCT06979895Recruiting

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer

Role: lead

NCT07788196Phase 2Recruiting

A Clinical Study Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB-II Gastric Cancer With High HER2 Expression.

Role: lead

NCT07780929Not ApplicableRecruiting

A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis

Role: lead

NCT07769892Recruiting

A Multicenter Prospective Observational Cohort Study for Digestive Tract Tumor Screening Using Multi-Target Blood and Fecal Biomarkers

Role: lead

NCT07712107Not ApplicableRecruiting

A Study on Gastrointestinal Cancer Screening Using a Multi-Targeted Combined Detection Model

Role: lead

NCT06914440Phase 2Recruiting

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Role: lead

NCT03115931Completed

The Effect of Perioperative Nutritional Assessment and Nutritional Support on Clinical Outcomes

Role: collaborator

NCT07600125Recruiting

Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers

Role: lead